Grand Challenges RfP: Innovations for Gram-Negative Antibiotic Discovery

The ultimate objective of Gr-ADI will be to enable discovery of safe and simple first-line broad-spectrum drugs for syndromic management, through:

1. Development of novel and emerging biological, chemical, and AI tools that could be applied broadly for antibiotic discovery to identify new antibiotic targets.
2. Application of these innovative approaches to generate chemical starting points for project-based drug discovery.
3. Fostering a collective mindset to address gaps in knowledge, solve problems, and manage a portfolio of targets and hits.

Funding: $5,000,000 total 

Duration: 3 years

Research Authority due date: 18.3.25